CHP 4 (W.W.)

规格:

货期:

编号:TS212366

品牌:Testobio

产品名称：	CHP 4 (W.W.)
商品货号：	TS212366
Organism：	Homo sapiens, human
Cell Type：	fibroblast
Product Format：	frozen
Morphology：	fibroblast
Culture Properties：	adherent
Biosafety Level：	1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Age：	8 years
Gender：	male
Ethnicity：	Black
Applications：	Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy Cell line CHP3, ATCC CCL-132.
Karyotype：	normal human male; diploid; stable
Derivation：	This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy Cell line CHP3, ATCC CCL-132.
Clinical Data：	This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. male Black 8 years
Comments：	This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy Cell line CHP3, ATCC CCL-132.
Complete Growth Medium：	The base medium for this cell line is ATCC-formulated Eagles Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing：	Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended Protocol: Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with Ca++/Mg++ free Dulbeccos phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal. Add 2.0 to 3.0 ml of complete growth medium and aspirate cells by gently pipetting Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37C.
Cryopreservation：	Freeze medium: complete growth medium, 95%; DMSO, 5%
Isoenzymes：	G6PD, B
Name of Depositor：	WJ Mellman
Deposited As：	Homo sapiens
References：	. . J. Pediatr. 68: 551, 1966. Segal S, et al. The metabolism of galactose by patients with congenital galactosema. Am. J. Med. 38: 62-70, 1965. PubMed: 14247292

首页 > 产品中心 > 微生物培养 > 菌株 > null > CHP 4 (W.W.)

产品中心 Product Center

联系我们CONTACT US

0574-87917803
24小时服务热线
testobio@163.com
销售邮箱
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址

联系方式

章丽敏
17757489010
朱静
18067106081
李晴
18067408036
李晶晶
13375187189
周雪
13372109301

CHP 4 (W.W.)

货号: TS212366
好评

询价

品牌 : TESTOBIO

加入购物车在线咨询

产品名称：	CHP 4 (W.W.)
商品货号：	TS212366
Organism：	Homo sapiens, human
Cell Type：	fibroblast
Product Format：	frozen
Morphology：	fibroblast
Culture Properties：	adherent
Biosafety Level：	1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Age：	8 years
Gender：	male
Ethnicity：	Black
Applications：	Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy Cell line CHP3, ATCC CCL-132.
Karyotype：	normal human male; diploid; stable
Derivation：	This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy Cell line CHP3, ATCC CCL-132.
Clinical Data：	This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. male Black 8 years
Comments：	This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia. This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells. Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al. His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy Cell line CHP3, ATCC CCL-132.
Complete Growth Medium：	The base medium for this cell line is ATCC-formulated Eagles Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing：	Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended Protocol: Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with Ca++/Mg++ free Dulbeccos phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal. Add 2.0 to 3.0 ml of complete growth medium and aspirate cells by gently pipetting Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37C.
Cryopreservation：	Freeze medium: complete growth medium, 95%; DMSO, 5%
Isoenzymes：	G6PD, B
Name of Depositor：	WJ Mellman
Deposited As：	Homo sapiens
References：	. . J. Pediatr. 68: 551, 1966. Segal S, et al. The metabolism of galactose by patients with congenital galactosema. Am. J. Med. 38: 62-70, 1965. PubMed: 14247292